BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24174662)

  • 1. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.
    Paul SM; Doherty JJ; Robichaud AJ; Belfort GM; Chow BY; Hammond RS; Crawford DC; Linsenbardt AJ; Shu HJ; Izumi Y; Mennerick SJ; Zorumski CF
    J Neurosci; 2013 Oct; 33(44):17290-300. PubMed ID: 24174662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices.
    Sun MY; Izumi Y; Benz A; Zorumski CF; Mennerick S
    J Neurophysiol; 2016 Mar; 115(3):1263-72. PubMed ID: 26745248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxysterols Modulate the Acute Effects of Ethanol on Hippocampal
    Izumi Y; Mennerick SJ; Doherty JJ; Zorumski CF
    J Pharmacol Exp Ther; 2021 Apr; 377(1):181-188. PubMed ID: 33441369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation.
    Sun MY; Taylor A; Zorumski CF; Mennerick S
    PLoS One; 2017; 12(3):e0174416. PubMed ID: 28346482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different oxysterols have opposing actions at N-methyl-D-aspartate receptors.
    Linsenbardt AJ; Taylor A; Emnett CM; Doherty JJ; Krishnan K; Covey DF; Paul SM; Zorumski CF; Mennerick S
    Neuropharmacology; 2014 Oct; 85():232-42. PubMed ID: 24878244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
    Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J
    Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.
    Sun MY; Linsenbardt AJ; Emnett CM; Eisenman LN; Izumi Y; Zorumski CF; Mennerick S
    Neuroscientist; 2016 Apr; 22(2):132-44. PubMed ID: 25628343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.
    Emnett CM; Eisenman LN; Mohan J; Taylor AA; Doherty JJ; Paul SM; Zorumski CF; Mennerick S
    Br J Pharmacol; 2015 Mar; 172(5):1333-47. PubMed ID: 25377730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors.
    Izumi Y; Auberson YP; Zorumski CF
    J Neurosci; 2006 Jul; 26(27):7181-8. PubMed ID: 16822975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.
    Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H
    Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological characterization of SAGE-718, a novel positive allosteric modulator of N-methyl-d-aspartate receptors.
    Beckley JT; Aman TK; Ackley MA; Kazdoba TM; Lewis MC; Smith AC; Farley BJ; Dai J; Deats W; Hoffmann E; Robichaud AJ; Doherty JJ; Quirk MC
    Br J Pharmacol; 2024 Apr; 181(7):1028-1050. PubMed ID: 37698384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloprotease 3 Activity Supports Hippocampal EPSP-to-Spike Plasticity Following Patterned Neuronal Activity via the Regulation of NMDAR Function and Calcium Flux.
    Brzdąk P; Włodarczyk J; Mozrzymas JW; Wójtowicz T
    Mol Neurobiol; 2017 Jan; 54(1):804-816. PubMed ID: 27351676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
    Izumi Y; Zorumski CF
    J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice.
    Radosevic M; Planagumà J; Mannara F; Mellado A; Aguilar E; Sabater L; Landa J; García-Serra A; Maudes E; Gasull X; Lewis M; Dalmau J
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34903638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity.
    Sakurai F; Yukawa T; Kina A; Murakami M; Takami K; Morimoto S; Seto M; Kamata M; Yamashita T; Nakashima K; Narita N; Bettini E; Ugolini A; Corsi M; Hasui T
    Bioorg Med Chem; 2022 Feb; 56():116576. PubMed ID: 35051811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons.
    Wei X; Nishi T; Kondou S; Kimura H; Mody I
    Neuropharmacology; 2019 Apr; 148():11-20. PubMed ID: 30594698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
    Mony L; Kew JN; Gunthorpe MJ; Paoletti P
    Br J Pharmacol; 2009 Aug; 157(8):1301-17. PubMed ID: 19594762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term potentiation and the role of N-methyl-D-aspartate receptors.
    Volianskis A; France G; Jensen MS; Bortolotto ZA; Jane DE; Collingridge GL
    Brain Res; 2015 Sep; 1621():5-16. PubMed ID: 25619552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.
    Nouhi M; Zhang X; Yao N; Chergui K
    CNS Neurosci Ther; 2018 Feb; 24(2):144-153. PubMed ID: 29230960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.